135 results
Page 2 of 7
424B5
6rad dklpfb
16 Feb 21
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
bvjk6jh8wiu7 dlz5
28 Dec 20
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results
5:28pm
8-K
EX-99.1
13x96ku93m d5j
15 Dec 20
Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I
7:06am
8-K
EX-99.1
zfo gamukzo
6 Nov 20
Other Events
11:15am
8-K
EX-99.1
1616ne
15 Oct 20
Regulation FD Disclosure
7:02am
424B5
6ad6utrb4xpq63nllcbo
2 Jul 20
Prospectus supplement for primary offering
5:23pm
424B5
0detxc
1 May 20
Prospectus supplement for primary offering
7:06am
424B5
ec45v 855
1 May 20
Prospectus supplement for primary offering
7:01am
424B5
gyx0ya1
13 Sep 19
Prospectus supplement for primary offering
5:06pm
424B5
71fwl
12 Jun 19
Prospectus supplement for primary offering
5:01pm
424B5
fb41piyrtionn8uly9h5
18 Mar 19
Prospectus supplement for primary offering
12:00am